The U.S. Food and Drug Administration (FDA) has announced the approval of lurbinectedin (Zepzelca; Jazz Pharmaceuticals) in...
Month: October 2025
At The University of Texas MD Anderson Cancer Center, a dedicated opioid stewardship program is setting a...
The battle against the opioid epidemic requires more than just new medications; it demands a transformation in...
In a setting often overlooked by standard regulations, the University of Texas MD Anderson Cancer Center has...
A systematic review and meta-analysis recently published in Human Vaccines & Immunotherapeutics has strongly affirmed the effectiveness...
The Food and Drug Administration (FDA) has approved a second generic version of the abortion medication mifepristone...
A Phase 3 study has demonstrated that SYSA1902 (CSPC Pharmaceutical Group), a biosimilar to the biologic drug...
Amid a complex and often contradictory health care landscape, pharmacists are proving to be essential, front-facing, and...
A multicenter study from South Korea highlights a critical and severe complication of COVID-19: a heightened risk...
Overestimation Alert: Study Suggests CGMs Misrepresent Blood Sugar Impact of Foods in Healthy Adults
Overestimation Alert: Study Suggests CGMs Misrepresent Blood Sugar Impact of Foods in Healthy Adults
A recent study from the University of Bath has raised critical concerns about the accuracy of Continuous...
